LSA
SAGE

L & S Advisors’s Sage Therapeutics SAGE Stock Holding History

L & S Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,745
Closed -$806K – 330
2019
Q3 		$806K Sell
5,745
-100
-2% -$16.7K 0.11% 196
2019
Q2 		$1.07M Buy
5,845
+605
+12% +$103K 0.14% 164
2019
Q1 		$833K Buy
+5,240
New +$759K 0.11% 189

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

L & S Advisors's SAGE Position: Q4 2019 in Review

L & S Advisors sold out of Sage Therapeutics (SAGE) in Q4 2019, closing a stake of 5,745 shares — an estimated $806K sold.

L & S Advisors first reported a position in SAGE in Q1 2019 and held it in 3 quarters. The position peaked at $1.07M in Q2 2019. 266 funds tracked by Wall St. Rank hold SAGE as of Q4 2019.

  • L & S Advisors reported no remaining Sage Therapeutics position as of Q4 2019 after selling out during the quarter.
  • L & S Advisors sold 5,745 Sage Therapeutics shares in Q4 2019, an estimated $806K.
  • L & S Advisors first reported a position in Sage Therapeutics in Q1 2019 and held it in 3 quarters.
  • L & S Advisors's Sage Therapeutics position peaked at $1.07M in Q2 2019.
  • 266 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2019.

Based on L & S Advisors's 13F filing for Q4 2019, filed 13 Feb 2020.